摘要
目的:为心肌缺血后适应药物治疗提供参考。方法:采用文献综述法,阐述近5年来缺血后适应药物治疗对心肌保护的研究和进展,并提出今后的努力方向。结果与结论:心肌缺血后适应药物治疗可减少或避免心肌缺血再灌注损伤的发生和发展,减少梗死面积,保护心肌的正常功能,为临床使用安全、有效的药物治疗提供新的方法,为临床上治疗心肌缺血的药物提供新思路。
出处
《中国药房》
CAS
CSCD
2014年第2期159-161,共3页
China Pharmacy
参考文献18
-
1Roger VL, Go AS, Lloyd-Jones DM, et al.Heart disease and stroke statistics 2012 update: a report from the Ameri- can Heart Association[J]. Circulation, 2012,125 ( 1 ) : e2.
-
2Anvari MA, Imani A, Faghihi M, et al.The administra- tion of oxytocin during early reperfusion, dose-depend- ently protects the isolated male rat heart against ischemia/ reperfusion injury[J]. Eur J Pharmacol, 2012,682 (1/3) : 137.
-
3van der Pals J, Koul S, Gtitberg MI, et al.Apyrase treat- ment of myocardial infarction according to a clinically ap- plicable protocol fails to reduce myocardial injury in a por- cine model[J]. BMC Cardiovasc Disord, 2010,10( 1 ) : 1.
-
4Huhn R, Heinen A, Weber NC, et al.Ischaemie and mor- phine-induced post-conditioning: impact of mK (Ca) channels[J]. Br JAnaesth, 2010,105(5) :589.
-
5Penna C, Mancardi D, Tullio F, et al.Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion[J]. Basic Res Cardiol, 2008,103 (4) : 368.
-
6Sorrentino SA, Doerries C, Manes C, et al.Nebivolol ex- erts beneficial effects on endothelial function, early endo- thelial progenitor ceils, myocardial neovaseularization, and left ventricular dysfunction early after myocardial in- farction beyond conventional betal-blockade[J]. J Am Coll Cardiol, 2011,57(5) : 601.
-
7Mewton N, Croisille P, Gahide G, et al. Effect of cyclo- sporine on left ventricular remodeling after reperfused myocardial infarction[J]. J Am Coil Cardiol, 2010, 55 (12) : 1 200.
-
8Halestrap AP.What is the mitochondrial permeability tran- sition pore?[J]. J Mol Cell Cardiol, 2009,46 (6) : 821.
-
9Ambrosio G, Del Pinto M, Tfitto I, et al.Chronic nitrat therapy is associated with different presentation and evolu- tion of acute ,coronary syndromes: insights from 52 693 patients in the global registry of acute coronary events[J]. Eur Heart J, 2010,31 (4) :430.
-
10Botha P, MacGowan GA, Dark JH.Sildenafil citrate aug- ments myocardial protection in heart transplantation[J]. Transplantation, 2010,89 (2) : 169.
同被引文献53
-
1Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocar-dium[J]. Circulation, 1986, 74(5): 1 124-136.
-
2Gonzez-Salazar A, Molina-Jij6n E, Correa F, et al. Cur- cumin protects from cardiac reperfusion damage by attenua- tion of oxidant stress and mitochondrial dysfunction [ J ]. Cardiovasc Toxicol, 2011, 11 : 357-364.
-
3Hong D, Zeng X, Xu W, et al. Altered profiles of gene expression in curcumin-treated rats with experimentally in- duced myocardial infarction[ J]. Pharmacol Res, 2010, 61 (2) : 142-148.
-
4Katanasaka Y, Sunagawa Y, Hascgawa K, et al. Applica- tion of cureumin to heart failure therapy by targeting tran- scriptional pathway in cardiomyocytes [ J ]. Biol Pharm Bull, 2013, 36(1):13-17.
-
5Avci G1, Kadioglu H, Sehirli AO, et al. Curcumin pro- tects against ischemia/reperfusion injury in rat skeletal muscle[J]. J Surg Res, 2012, 172(1) : e39-46.
-
6Waiters AM, Porter GA Jr, Brookes PS. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy [J]. Circ Res, 2012, 111(9) : 1 222-236.
-
7Jiang B, Zhang B, Liang P, et al. Nucleolin protects the heart from ischaemia-reperfusion injury by up-regulating heat shock protein 32[J]. Cardiovasc Res, 2013, 99(1) : 92-101.
-
8Sun Z, Tong G, Ma N, et al. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial is- chemia-reperfusion injury [ J]. Basic Res Cardiol, 2013, 108(3) : 341-345.
-
9Sahin K, Orhan C, Tuzcu Z, et al. Curcumin ameloriates heat stress via inhibition of oxidative stress and modulation of Nrt2/HO-1 pathway in quail [ J ]. Food Chem Toxicol, 2012, 50(11) : 4 035-041.
-
10Nemmar A, Subramaniyan D, Ali BH. Protective effect of curcumin on pulmonary and cardiovascular effects induced by repeated exposure to diesel exhaust particles in mice [J]. PLoS One, 2012, 7(6) : e39 554.
引证文献5
-
1姚博华,蒋卫红.姜黄素后处理通过血红素氧合酶1发挥对心肌缺血/再灌注损伤的保护作用[J].中国动脉硬化杂志,2014,22(7):685-689. 被引量:6
-
2吴娜,宋达琳,蔡尚郎.硝酸盐后处理对心肌缺血再灌注损伤过程中内质网应激的影响研究[J].中国心血管病研究,2016,14(5):470-473.
-
3杨桑杰草,贾海明,杨雯,贾彬彬,米泰宇,乔小民.美托洛尔联合单硝酸异山梨酯治疗围手术期心肌缺血患者疗效及安全的研究[J].卫生职业教育,2016,34(24):158-159. 被引量:3
-
4姜中慧,李克婷,田家玮,刘宇杰,冷晓萍,任敏.斑点追踪成像多层分析技术评价兔心肌缺血药物后适应模型左心室纵向心肌功能变化[J].中华超声影像学杂志,2017,26(1):65-70. 被引量:4
-
5毕亮亮,韩若凌,焦子义.二维斑点追踪超声心动图在实验动物兔中的应用进展[J].中国医药导报,2019,16(36):50-53. 被引量:2
二级引证文献15
-
1郭朝晖,颜苗,张毕奎.核因子E2相关因子2对心肌缺血再灌注损伤的保护作用研究进展[J].中国临床药理学杂志,2015,31(23):2366-2369. 被引量:1
-
2张宇,李建锋,单红燕,伏瑶,赵启韬.中药调节心肌缺血再灌注损伤的活性成分及作用机制[J].辽宁中医杂志,2016,43(8):1709-1713. 被引量:16
-
3孔凡峰,颜紫宁,范莉,黄俊.分层应变评价兔急性心肌缺血早期左室收缩功能的改变[J].现代医学,2017,45(11):1562-1568.
-
4陈雨,林振宇,谷阳,严山,张喜文.姜黄素对大鼠心肌缺血再灌注损伤的心肌保护作用[J].临床和实验医学杂志,2018,17(22):2374-2378. 被引量:10
-
5郭德友.疏血通联合单硝酸异山梨酯治疗老年无症状心肌缺血疗效分析[J].海峡药学,2018,30(10):143-144. 被引量:4
-
6商新闻,王永.丹参川芎嗪注射液联合硝酸异山梨酯治疗心肌缺血患者的临床疗效及安全性观察[J].临床医药文献电子杂志,2018,5(5):162-162.
-
7毕亮亮,韩若凌,焦子义.二维斑点追踪超声心动图在实验动物兔中的应用进展[J].中国医药导报,2019,16(36):50-53. 被引量:2
-
8赵联璧,邢长洋,杨沛,柴国虎,王海燕,郭万刚,袁丽君.超声心动图观察经皮冠状动脉介入术后心肌缺血再灌注损伤[J].中国医学影像技术,2020,36(1):16-20. 被引量:13
-
9陈晓菲,姜志荣,孙品,何香芹,王小凡,吕启凤,宋晓霞,田雨.三维斑点追踪技术联合SYNTAX评分评价复杂冠状动脉疾病[J].中国医学影像技术,2020,36(4):529-534. 被引量:6
-
10曾海波,徐均.斑点追踪技术在高血压患者左心房功能早期改变评价中的应用[J].大医生,2020,5(13):55-57.
-
1张文婷,李方江,王小元,李清,张强,李会贤.山莨菪碱联合芬太尼后处理对兔心肌缺血再灌注代谢指标的影响[J].中国临床药理学杂志,2014,30(4):337-339. 被引量:1
-
2康健.红花注射液所致不良反应60例分析[J].医药导报,2010,29(11):1520-1521. 被引量:4
-
3王伟华,郑逸华,周爱新,林雪梅,毛娟华,李振华.莫西沙星治疗恶性肿瘤合并医院获得性肺炎的疗效观察[J].中华医院感染学杂志,2011,21(22):4794-4796. 被引量:1
-
4丁茹,顾兴建.动态血压监测评价复方替米沙坦的降压疗效[J].中国临床药学杂志,2008,17(2):79-81. 被引量:3
-
5张丽娜,吴玉林.药物后适应在心肌缺血再灌注损伤中的保护作用[J].药学进展,2008,32(4):157-162. 被引量:4
-
6张抗怀,黄泰康.成人万古霉素血药浓度监测的探讨[J].中国临床药理学杂志,2010,26(2):157-160. 被引量:30
-
7张静.临床药师的职责、使命与努力方向[J].首都医药,2009(13):50-51.
-
8周舒君,仇峰,杨世海,杨美华.伏立康唑的体外及体内药动学研究进展[J].中国药房,2012,23(41):3918-3920. 被引量:3
-
9张石革.抗高血压药治疗的药学监护[J].中国药房,2010,21(42):3948-3951. 被引量:27
-
10陈腊霞,王燕燕.中医药治疗类风湿关节炎的研究进展[J].中国药房,2013,24(15):1420-1422. 被引量:23